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Abstract
Background: It is suggested that an elevated left atrial pressure (LAP) promotes ectopic beats 
emanating  in  the  pulmonary  veins  (PVs)  and  that  LAP might  be  a  marker  for  structural 
remodeling. This study aimed to identify if the quantification of LAP correlates with structural 
changes of the LA and may therefore be associated with outcomes following pulmonary vein 
isolation  (PVI).                                        
Methods: We analysed data from 120 patients, referred to PVI due to drug-refractory atrial  
fibrillation (AF) (age 63±8; 57% men). The maximum (mLAP) and mean LAP (meLAP) were 
measured  after  transseptal  puncture.                                          
Results  and Conclusions: Within a mean follow-up of 303±95 days,  60% of the patients 
maintained in sinus rhythm after the initial procedure and 78% after repeated PVI. Performing 
univariate Cox-regression analysis, type of AF, LA-volume (LAV), mLAP and the meLAP 
were significant predictors of recurrence after PVI (p=0.03; p=0.001; p=0.01). In multivariate 
analysis mLAP>18mmHg, LAV>100 ml and the presence of persistent AF were significant 
predictors (p=0.001; p=0.019; p=0.017). The mLAP >18 mmHg was associated with a hazard 
ratio of 3.8. Analyzing receiver-operator characteristics, the area under the curve for mLAP 
was 0.75 (p<0.01).  mLAP >18 mmHg predicts  recurrence  with a sensitivity  of 77 % and 
specificity of 60 %. There was a linear correlation between the LAV from MDCT and mLAP 
(p = 0.01, R2 = 0.61). The mLAP measured invasively displays a significant predictor for AF 
recurrence after PVI. There is a good correlation between LAP and LAV and both factors may 
be  useful  to  quantify  LA  remodeling.                                      
Keywords: atrial  fibrillation,  pulmonary  vein  ablation,  predictors,  left  atrial  pressure, 
remodeling,  left  atrial  volume                                         
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Introduction
Atrial Fibrillation (AF) is the most common sustained arrhythmia worldwide with a raising 
prevalence in the elderly patients. [1] AF is regularly associated with decreased quality of life 
as well as increased morbidity and mortality [2]. In recent years, catheter based ablation for 
pulmonary vein isolation (PVI) evolved to be the therapy of choice for treatment  of drug 
refractory AF. Although PVI is successful in most of the patients, the long term success rates 
vary [3,4]. Long-term efficacy of PVI is depended of multiple factors and still  difficult  to 
predict  for an individual patient.  Further research is essential  to assess a large number of 
reliable  predictors  offering  the  opportunity  to  anticipate  the  individual  risk  for  AF/AT 
recurrence following catheter ablation. Previous data suggests that LA-remodeling plays an 
important role for AF/Atrial tachycardia (AT)-recurrence after PVI. However, LA remodeling 
is an electrical and anatomical process and therefore difficult to measure directly [5,6]. In this 
context there is already evidence that the type of AF, LA-dimensions, LA-anatomy and LA-
volume may be related to left atrial remodeling and might therefore have the potential to act as 
significant predictors for AF recurrence after PVI [7,8]. In addition, a recent study discussed 
that elevated left atrial pressure (LAP) depicts a possible trigger for AF by causing ectopic 
beats emanating from the pulmonary veins (PVs) [9].                                        
It  is  still  unclear  whether  elevated  LAP has  a  significant  effect  on freedom from AF/AT 
recurrence after PVI and whether this physiological parameter relates directly to anatomical 
and  structural  changes  of  the  LA.  Our  aim was  therefore  to  prospectively  analyze  if  the 
quantification of LAP is associated with the outcome following PVI.                                
Methods
Patient  selection                                            
120 consecutive patients with drug-refractory, symptomatic paroxysmal or persistent AF were 
included in this study. All patients underwent PVI between November 2009 and April 2012 at 
our  clinic.  All  interventions  were  performed  with  at  least  one  well-experienced 
electrophysiologist and usually one or two cardiologists in training. Every patient underwent 
circumferential isolation using radiofrequency (RF) lesions. All clinical and procedural data 
were prospectively recorded. Written informed consent was obtained from each patient prior 
to  the  ablation  procedure  and  the  study  was  approved  by  the  institutional  review  board. 
According  to  the  HRS consensus  paper  from 2007,  paroxysmal  AF was  defined  as  self-
terminating episodes lasting less than 7 days. Persistent AF was defined as AF lasting more 
than  7  days,  and/or  requiring  electrical  or  pharmacological  cardioversion  [10].  Exclusion 
criteria were hyperthyroidism, LA thrombus, decompensated heart failure, stroke, myocardial 
infarction  or  gastrointestinal  bleeding  within  4  weeks  prior  to  the  intervention.  Primary 
endpoint  of this  study was defined as long-term procedural  success,  defined as  long-term 
freedom from any AT/AF episodes irrespective of symptoms after the index procedure during 
12 months of follow-up. Secondary endpoints were procedure-related complications defined 
as death, atrio-esophageal fistulae, pulmonary vein stenosis requiring interventions, pericardial 
tamponade requiring intervention, phrenic nerve paralysis.                                    
Echocardiography
Transthoracic  echocardiography  (TTE)  and transesophageal  echocardiography  (TEE)  were 
routinely performed prior PVI. The TTE images were obtained from parasternal long- and 
short-axis views, apical four-chamber, two-chamber, and long-axis views. TEE was needed 
for  exclusion  of  thrombus  formation  in  the  atria.  All  echocardiographies  were  performed 
according to the guidelines of the American Society of Echocardiography. [11]               
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Multidetector  computed  tomography                                            
All  patients  underwent  ECG-gated  64-slice  MDCT  (VCT  LightSpeed  GE  Healthcare, 
Milwaukee, WI, USA) within 24-48 h prior to PVA using our local LA protocol. [12] Briefly,  
heart rate was kept below 70 bpm using beta-adrenergic blocking agents if necessary. A spiral 
scan using retrospective gating was performed during a single breath-hold to examine the 
heart from the supraaortic region to the upper abdomen. In all cases, 80 mL of intravenous 
contrast  agent  (Imeron  350,  Bracco  Imaging,  Konstanz,  Germany)  was  injected. 
Semiautomatic bolus detection in the ascending aorta was used for optimal contrast timing. 
Imaging parameters included gantry rotation time of 350 ms, detector  collimation of 64 x 
0.625 mm, and a tube voltage of 120 kV. Semi-automatic dose reduction schemes were used. 
The  radiation  exposures  range  between  6.24  and  10.31  mSv.  An  ECG-gated  half-scan 
algorithm was applied to reconstruct the data into axial images with a slice thickness of 0.625 
mm. Ten phases within the cardiac cycle were reconstructed at 10% RR interval and the end-
systolic phase of the LA selected as either 70 or 80% of RR length. MDCT images were 
analysed  offline  by  experienced  independent  readers  (at  least  one  radiologist  and  one 
cardiologist)  on a standard workstation with a dedicated cardiac imaging software package 
(VolumeShare 2, GE Healthcare). For each patient, anatomy of the LA, the PVs, and LAV 
were identified. As previously described, the two-dimensional LA area was manually traced 
on each MDCT slice from the LA roof to the level of the mitral annulus. The PVs were cut at  
the  PV ostia  and  the  LAA was  excluded  at  its  base.  The LA volume was  automatically 
calculated and reported. For the ablation procedure, 3D MDCT images of the LA and the PV 
were reconstructed on a separate workstation and integrated with electroanatomical mapping 
(CARTO Merge,  Biosense Webster,  Diamond Bar, CA, USA).                           
Electrophysiological  study and measurement of left  atrial  pressure                      
All ablation procedures were performed using a remote magnetic navigation system (RMN), 
the Niobe II magnetic navigation system (Stereotaxis) and a joystick-controlled motor drive 
(Cardiodrive, Stereotaxis).  The RMN system has been described previously13. Access was 
achieved  from  the  femoral  veins  in  any  cases.  A  6F  steerable  decapolar  catheter  (Bard 
Dynamic Tip, Bard Inc., Lowell, MA, USA) was positioned in the coronary sinus. It was used 
as  reference  catheter  during  mapping  and  ablation  process.  After  fluoroscopically  guided 
transseptal puncture (TSP) a SL 1 sheath (St. Jude Medical, Inc., St. Paul, MN, USA) was 
inserted into the LA. At this point the LAP was measured invasively using the monitored 
pressure curve. The maximum LA pressure (mLAP) was defined as the maximum height of 
the v wave, and the minimum LA pressure (miLAP) was defined as the minimum of the x 
trough in case of SR during measurement or the lowest value of the pressure curve in the case 
of  AF  during  measurement.  After  this  measurement,  a  3.5  mm  open-irrigated,  magnetic 
mapping and ablation catheter (Navistar Thermocool RMT, Biosense Webster, Diamond Bar, 
USA) was advanced through the sheath into the LA. Mapping was performed using a 3D-
mapping  system  (CARTO  Merge,  Biosense  Webster,  Diamond  Bar,  CA,  USA).  The 
radiofrequency (RF) generator (Stockert, Biosense Webster) was set to temperature controlled 
RF delivery with a target temperature of 45ºC and a nominal power limit of 40 W (flow 30 
ml/min).  At the posterior LA wall the output was limited to 30 W (flow 17 ml/ min). RF 
current  was  applied  for  30-60  s  until  local  electrogram  amplitude  was  reduced  by  80%. 
Endpoint  of  the  ablation  procedure  was  the  electrical  isolation  of  all  PVs  defined  as 
bidirectional  conduction  block.  Conduction  block  was  confirmed  by  careful  and  repeated 
mapping for residual potentials around the entire circumference of the PV ostia, and pacing 
from multiple sites within the circumferential line. For this purpose, the entire ablation line 
was mapped after  the first  anatomical  circumferential  attempt to detect  residual  potentials 
representing  local  conduction.  If  necessary,  additional  ablation  lesions  were  added. 
Afterwards, the complete ablation line was re-mapped again during pacing from the distal pair 
of electrodes of the RMN catheter with an output of 10 V/2 ms (Biotronik UHS 3000 Control 
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Unit, Biotronik GmbH) and the presence or absence of LA capture was evaluated using the 
atrial signal of the coronary sinus catheter. If no capture was detected, the line was considered 
as complete at this specific location. In case of LA capture a gap was suspected and ablation 
was  continued  [14,15].                                   
An echocardiogram was performed within  24h after  index procedure  to  detect  pericardial 
effusion.  
Follow-up
Daily 12-lead surface ECGs and telemetry until discharge were used to confirm sinus rhythm. 
Additional antiarrhythmic drug therapy was prescribed for the first 3 to 6 months if necessary 
and oral anticoagulation was started the day after PVI with a target INR of 2.0-3.0. Bridging 
with unfractionated or low molecular weight heparin was initiated 6-12 h after the ablation 
procedure. After hospital discharge, all patients were scheduled in our outpatient clinic 3, 6, 9 
and 12 months following PVI.  Upon every visit, patients were asked for symptoms of AF/AT 
recurrence,  documented  arrhythmia  recurrences,  and  current  medication.  Moreover, 
ambulatory Holter monitoring was performed at each visit for 96h to detect symptomatic or 
asymptomatic  AF/AT  recurrences.  All  patients  were  advised  to  present  themselves 
immediately  in  the  case  of  symptoms suggestive  of  AF/AT recurrence  in  order  to  obtain 
necessary treatment  and ECG documentation.  An AF/AT episode lasting longer than 30 s 
outside a blanking period of 3 months after the index procedure was considered as recurrent 
AF/AT.  
Statistical  analysis                                         
Statistical  analysis  was  performed  using  SPSS  for  Windows  (Version  20.0,  SPSS  Inc., 
Chicago,  IL,  USA).  Continuous  variables  are  expressed  as  mean  ±  standard  deviation. 
Normally distributed data were compared using the independent Student's T-test. A P-value < 
0.05 was considered as statistically significant. A Kaplan-Meier (KM) analysis of the median 
value of a continuous parameter was used as the standard cutoff value. Freedom from AF/AT 
recurrence  for  the  dichotomized  patient  groups  was  compared  using  logistic  regression. 
Multivariate logistic or Cox regression analysis was performed to assess those factors that 
achieved significance in univariate analysis. Receiver operating characteristic (ROC) analysis 
was performed to assess the predictive value of parameters for ablation success. The area 
under the ROC-curve (AUC) as well as the asymptotic significance were calculated. A linear 
regression model was used to determine linear correlations. Results are given with Pearson's 
"R".  The  Spearman  Rho  coefficient  was  calculated  to  spot  non-linear  correlations.
Results
Patient  details                                          
A  total  number  of  120  consecutive  patients,  aged  63  ±  8  years,  including  168  ablation 
procedures were analyzed. The clinical baseline characteristics of the entire study population 
are presented in Table 1. In all patients at least one antiarrhythmic drug failed prior catheter 
ablation. Those were amiodarone (43%), dronedarone (33%), and flecainide (58%). Most of 
the patients had paroxysmal AF (58 %).  All patients underwent TTE, TEE and MDCT prior 
PVI without complications. 
Left  atrial  pressure                                      
Maximum LAP (mLAP) and mean LAP (meLAP) were significantly higher in patients with 
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AF/AT recurrence (mLAP p<0.01; meLap p<0.01). Furthermore the minimum LAP (miLAP) 
showed a strong tendency to the level of significance (miLap p=0.05; Figure 1). We observed 
a significant difference (p=0.047) regarding the amount of mLAP comparing patients with 
paroxysmal (PAF) and persistent AF (PERS).  
Table 1: Clinical parameters of all patients
 
P-Values are given for all parameters. LA volume (LAV) and type of atrial fibrillation (AF) differ significantly 
between patients with and without AF/AT recurrence (*=significant). 
Figure 1: Comparison of different left atrial pressure (LAP) measurements between patients with and without 
AF/AT recurrence. The level of LAP (mmHG) is displayed on the Y-axis. The figure demonstrates that mLAP 
and meLAP are significant elevated in patients with AF/AT recurrence (p<0.01). The miLAP shows a strong 
tendency  to  the  level  of  significance  too  (p=0.05).                                        
Procedural  success  and  AF recurrence                                            
The mean follow-up period was 303±94 days. At the end of this period 60% of the patients 
maintained sinus rhythm after  the initial  ablation  procedure and 78% after additional  PVI 
(including 1.4±0.5 ablation procedures,  Figure 2).                                            
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Figure  2: A  AF/AT recurrence-free  survival  after  one  ablation  procedure.  B  Overall  survival  after  1-year 
including addition ablation procedures. C Kaplan-Meier analysis of the mLAP >18 mmHg (dotted line) vs the 
mLAP <18 mmHg (solid line). The outcome is significantly lowered in the group with a mLAP >18 mmHg 
(p<0.01). D Kaplan Meier analysis of patients with persistent atrial fibrillation (AF) (dotted line) vs those with 
paroxysmal AF (solid line). The recurrence free intervall is significantly lowered in patients with persistent AF 
(p<0.01).
In  univariate  analysis  (using  Cox-Regression)  type  of  AF,  LA-Volume,  congestive  heart 
failure (CHF), mLAP and meLAP were significantly correlated with AF/AT recurrence after 
PVI (p=0.03; p=0.001; p=0.01). Multivariate analysis showed that type of AF, LA-volume and 
mLAP are independent predictors for recurrence (p=0.017; p=0.019; p=0.001). Performing a 
ROC-curve with maximum and meLAP, both curves reached the level significance of p<0.01. 
The AUC for the mLAP was higher than the one from meLAP (AUC=0.75 vs AUC=0.73). A 
mLAP greater than 18 mmHg predicts recurrence with a sensitivity of 77 % and specificity of 
60 %. Plotting the type of AF in a  KM-Curve it  reveals  a significant  difference  between 
paroxysmal  AF  and  persistent  AF  (Figure  2D;  log-rank  p=0.02).  Our  data  shows  that  a 
mLAP>18 mmHg is associated with a Hazard ratio (HR) of 3.8 (Fig 2C; log-rank: p<0.01). 
Moreover, the presence of persistent AF is associated with a HR of 2.0 for AF/AT recurrence 
in multivariate analysis. In addition,  LAV more than 100 ml goes within a HR of 2.1 for 
recurrence (Table 2). 
Table 2: Summary of the significant predictors in multivariate regression analysis 
(mLAP=maximal left atrial pressure; LAV=left atrial volume: AF=atrial fibrillation; CI=confidence interval; 
*=significant). 
There  were  no  major  complications  requiring  intervention.  Pericardial  effusion  (n=2)  and 
haematoma at the puncture site (n=1) were documented as minor complications, none of these 
required  intervention.                                        
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Correlation  between  LAP  and  LA  dimension
Spearmans rank correlation was performed to examine if there is a direct correlation between 
LAP  and  other  clinical  characteristics.  Linear  regression  analysis  showed  a  significant 
correlation  between the LAV and the mLAP (r=0.81;  p=0.01*)  which is  demonstrated  in 
Figure 3. 
Figure 3: Linear regression model between the LAV (ml) on X-axis and the mLAP (mmHg) on Y-axis. Pearsons 
r is 0.81 (p=0.01).  Whereas the other two pressure parameters did not show sufficient linear correlation to the 
LAV. There was also a linear correlation between persistent AF and mLAP (p=0.034; r=0.19; Figure 4). 
 
Figure 4: Bar graph displaying the correlation of maximum left atrial pressure (mLAP) to the type of AF. The  
mean mLAP is higher in patients with persistent atrial fibrillation (PERS; r=0.19; p=0.034) in contrast to patients 
with  paroxysmal  atrial  fibrillation  (PAF;  r=-0.12;  p=0.19).                                  
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Subgroup  analysis                                       
According  to  the  multivariate  regression  model  patients  were  categorized  into  4  groups. 
Patients were scheduled depending on the following characteristics: PERS, LAV >100ml and 
mLAP >18 mmHg.  Patients  with  none of  these  three  characteristics  were  summarized  in 
group 1 (n=24). Group 2 (n=28) consistent of patients with 1 out of the 3 factors. If 2 out of 3 
factors were positive, patients were categorized in group 3 (n=38). In case that all 3 out of 3  
factors were present, patients were categorized in group 4 (n=30). The patient characteristics 
of each patient group are presented in table 3. 
Table 3: Patient details divided into the different subgroups 
(PERS= persistent atrial fibrillation; congestive heart failure=CHF).  
Figure 5 shows the KM analysis for the 4 patient groups. After the mean follow up of 303±94 
days, 92% of the patients in group 1 were free of any recurrence after a single procedure. 
After the same period, there were 68% of the patients recurrence-free in group 2. In group 3 
38% and in group 4, where all  characteristics  were present, 26% were free of recurrence.
   
Figure  5: Kaplan-Meier  analysis  of  the  4  subgroups.  The  figure  demonstrates  that  the  more  risk  factors 
(persistent AF (PERS), left atrial volume (LAV)>100ml, maximum left atrial pressure (mLAP)>18 mmHg) are 
positive,  the  higher  is  the  possibilty  for  AF/AT  recurrence  (p=0.01).                            
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Discussion
Main  findings                                                 
The main finding of this prospective study is that mLAP and meLAP are good predictors for 
AF/AT recurrence after catheter ablation for AF (p<0.01). In multivariate analysis, an mLAP 
>18 mmHg was significantly associated with an elevated risk for AF/AT recurrence (HR 3.8). 
The  mLAP  shows  a  good  linear  correlation  to  LAV  (p=0.01).  Furthermore,  mLAP  is 
associated with a higher probability for the presence of persistent AF (p=0.03). In addition, 
mLAP>18 mmHg seems to be in close relationship to the presence of congestive heart failure, 
too  (p=0.05).                                         
The role of risk factors and LA remodeling to predict AF/AT recurrence                         
It is still of emerging interest, to find clinical predictors for AF/AT recurrence after PVI. Over 
the years, a lot of different predictors have already been described. Recent data suggests that 
LA dimensions  relate  to  the  success  rate  of  the  ablation  procedure.  Several  studies  have 
demonstrated that a LAV >100 ml significantly increases the risk for AF/AT recurrence after 
PVI9,16-18. Despite the LAV, the type of AF is a strong predictor for a successful ablation 
procedure, too19. In this context, the presence of persistent AF is associated with a poorer 
prognosis in comparison with paroxysmal AF20. Our results are in line with previous data, 
demonstrating  that  the LAV was a significant  predictor  in  multivariate  analysis  (p=0.019, 
Table  2).  Furthermore,  the  presence  of  persistent  AF  was  associated  with  a  significantly 
increased  risk  for  recurrence  (p=0.017,  Table  2).  Our  data  adds  valuable  information 
regarding the role of LAP in the context of AF/AT recurrence. We indicate that the mLAP 
was significantly associated with an increased risk for recurrence after PVI (p<0.01; HR=3.8; 
Table 2). Comparing the AUC, the mLAP showed a better correlation with AF/AT recurrence 
than the meLAP (AUC mLAP=0.75 vs AUC meLAP=0.73). These findings are in line with 
results, which have been published recently [21,22]. The studies also evaluated the role of 
LAP in context of AF/AT recurrence after PVI. The results of those studies corroborate the 
emerging role of LAP on freedom from AF/AT recurrence. In contrast to the other studies, 
PVI  was  performed  using  a  remote  magnetic  navigation  system (RMN) in  our  study.    
Based on these findings we suggest that all the three factors play an important role in the 
process of LA remodeling in patients with AF. Besides the anatomical remodeling, which can 
be visualized, there is evidence for additional electrical and physiological changes of the LA 
in patients with AF. In previous studies it could be shown that elevated LAP leads to changes 
in the electrical velocity of the myocardium with the potential to generate delay [23]. Those 
conduction  delays  may  trigger  micro-re-entry.  In  addition,  it  has  been  demonstrated  that 
elevated LAP increases the rate of waves emanating from the PVs [8] and an experimental 
study showed that an increase in LAP results in the development of AF [24]. This is in line 
with  our  findings  and  therefore  we  suggest  to  deem  the  elevated  LAP  as  an  important 
predictor for freedom from AF/AT recurrence after PVI.                                           
Furthermore, there is evidence, that ACE inhibitors may play a role in preventing AF [25,26]. 
As shown before Angiotensin II leads to an increase in LAP [27,28]. The protective effect of 
ACE inhibitors on the development of AF might be in the prevention of elevated LAP and 
therefore decelerating left atrial remodeling. This finding supports the importance of LAP in 
atrial  remodeling.                                           
Correlation between LAP and left atrial dimensions                                       
Previous data suggests that an enlargement of the LA relates to the level of LA remodeling. In 
this context,  the  elevation  of  the  LAV  has  been  shown  as  suitable  predictor  for  AF/AT 
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recurrence  in  several  studies  [16-18].  This  study  demonstrated  a  good  linear  correlation 
between the mLAP and meLAP to the LAV (rs=0.80; rs=0.76). Especially the mLAP showed 
a clear linear correlation with LAV (r=0.75, Figure 3). These findings could be explained by 
several reasons: First, the loss of the regular atria contraction during AF might lead to a severe 
volume overload in the LA and this might increase the LAP. The correlation between LAP 
and LAV has been reported earlier, our results confirm these findings [29,30].             
Second,  the  presence  of  CHF  showed  a  significant  correlation  with  the  miLAP  and  the 
meLAP. Independently of mitral valve diseases the presence of CHF and diastolic dysfunction 
is said to be associated with increased LAP [31]. Furthermore atrial fibrosis may lead to a 
decreased  ability  of  the  atrium to relax  resulting  in  a  dysfunction  similar  to  the  diastolic 
dysfunction  of  the  ventricle  [32].  This  could  be  an  explanation  for  the  correlation  of  the 
miLAP as an expression of the loss of atrial distensibility.                                     
Third, the presence of persistent AF correlated significantly with mLAP (p=0.017, rs=0.190). 
This finding alone is not surprising, as the other correlated factors can act as a precondition for 
the development of persistent AF [33]. The correlation of LAP with the LA-volume is highly 
significant. In addition, experimental models showed as well that even the induction of AF 
goes  within  elevation  of  LAP, independently  of  structural  heart  diseases  [34].            
Risk  stratification  for  AF  recurrence                                             
Even for the experienced electrophysiologist, it remains challenging to calculate an individual 
risk for AF/AT recurrence after PVI. We want to present an approach to categorize patients 
according to their  clinical  risk factors  and calculate  their  individual  risk based on cut off 
values.  Our  study  demonstrates  that  a  lot  of  risk  factors  correlate  with  each  other.  By 
combining  these  factors  it  was  possible  to  subdivide  the  patient  group  in  different  risk 
categories. We used an mLAP of >18 mm HG and a LAV >100 ml as cut-off values based on 
the  ROC.  As  shown  in  Figure  XY/Table  XY,  the  probability  for  freedom  from  AF/AT 
recurrence decreases, the more factors have reached the cut-off value. Patients categorized to 
group 4 have a relatively low probability for mid-term freedom from AF/AT recurrence of 
only  24%.                                        
For accurate use of the scoring-system, an invasive measurement of LAP is required, which is 
usually performed at the time of performing PVI. In order to have an unambiguous scoring 
before the procedure it might be useful to identify imaging based parameters e.g. in CT or 
echocardiography,  that  correlate  with  the  LAP.                               
Nevertheless, the demonstrated risk score based on clinical parameters could be an alternative 
to the recently publish risk stratification model by Marrouche et al . They suggested to predict 
the success rate of PVI based on pre-procedural fibrosis detected on MRI. In their study, atrial 
fibrosis was taken as expression of left atrial remodeling [35]. In contrast to this study, we 
used  parameters,  which  are  ascertained  routinely  prior  PVI.  In  addition  our  statistical 
calculation  is  less  time consuming and more cost-effective  than  using an MRI-based risk 
stratification alone. However, our data shows that our approach of individual risk stratification 
is feasible and lead to reproducible results. We would therefore suggest including this cut-off 
based  model  into  clinical  routine.                                      
Conclusion
LAP is a parameter easy to access during PVI. The maximum LAP displays a significant 
predictor for recurrence after PVI. There is a good correlation between LAP and LA-volume 
and both factors may be useful to quantify LA remodeling.                              
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